- Forums
- ASX - By Stock
- NEU
- Ann: Phase 2 trial shows significant improvements in Angelman
Ann: Phase 2 trial shows significant improvements in Angelman, page-73
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.78 |
Change
-0.230(1.77%) |
Mkt cap ! $1.644B |
Open | High | Low | Value | Volume |
$12.80 | $12.89 | $12.69 | $2.227M | 174.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 411 | $12.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.80 | 1043 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 122 | 12.780 |
7 | 768 | 12.770 |
5 | 854 | 12.760 |
5 | 1715 | 12.750 |
4 | 946 | 12.740 |
Price($) | Vol. | No. |
---|---|---|
12.790 | 6 | 1 |
12.800 | 1833 | 8 |
12.810 | 645 | 7 |
12.820 | 606 | 6 |
12.830 | 1093 | 8 |
Last trade - 12.26pm 16/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online